Oncotarget

Research Papers:

Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis

Olga Villamizar, Christopher B. Chambers, Janice M. Riberdy, Derek A. Persons and Andrew Wilber _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:13810-13826. https://doi.org/10.18632/oncotarget.7329

Metrics: PDF 2773 views  |   HTML 3913 views  |   ?  


Abstract

Olga Villamizar1,3,*, Christopher B. Chambers1,*, Janice M. Riberdy2, Derek A. Persons2 and Andrew Wilber1

1 Department of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, Illinois, USA

2 Department of Hematology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA

3 Department of Microbiology, Pontificia Universidad Javeriana, Bogotá, Colombia

* These authors have contributed equally to this work

Correspondence to:

Andrew Wilber, email:

Keywords: alternative splicing, apoptosis, Fas, long-noncoding RNA, Saf

Received: November 03, 2015 Accepted: January 29, 2016 Published: February 11, 2016

Abstract

In multicellular organisms, cell growth and differentiation is controlled in part by programmed cell death or apoptosis. One major apoptotic pathway is triggered by Fas receptor (Fas)-Fas ligand (FasL) interaction. Neoplastic cells are frequently resistant to Fas-mediated apoptosis, evade Fas signals through down regulation of Fas and produce soluble Fas proteins that bind FasL thereby blocking apoptosis. Soluble Fas (sFas) is an alternative splice product of Fas pre-mRNA, commonly created by exclusion of transmembrane spanning sequences encoded within exon 6 (FasΔEx6). Long non-coding RNAs (lncRNAs) interact with other RNAs, DNA, and proteins to regulate gene expression. One lncRNA, Fas-antisense or Saf, was shown to participate in alternative splicing of Fas pre-mRNA through unknown mechanisms. We show that Saf is localized in the nucleus where it interacts with Fas receptor pre-mRNA and human splicing factor 45 (SPF45) to facilitate alternative splicing and exclusion of exon 6. The product is a soluble Fas protein that protects cells against FasL-induced apoptosis. Collectively, these studies reveal a novel mechanism to modulate this critical cell death program by an lncRNA and its protein partner.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 7329